Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Moon-Sub Lee
Introduction
Moon-Sub Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of risperidone, a medication used to treat various mental health conditions. His innovative approach has led to a patented method that enhances the yield of this important compound.
Latest Patents
Moon-Sub Lee holds a patent for a method of preparing risperidone. This method involves the reaction of 2,4-difluorophenyl(4-piperidinyl)methanone oxime hydrochloride with 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one in an aqueous alkali hydroxide solution. The process is notable for achieving a high yield of risperidone, utilizing an alkali hydroxide concentration ranging from 20 to 40%.
Career Highlights
Moon-Sub Lee is currently associated with Hanmi Pharm. Co., Ltd., a leading pharmaceutical company in South Korea. His work at Hanmi Pharm has allowed him to focus on innovative drug development and contribute to advancements in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Nam-Du Kim and Jae-Heon Lee, who share a commitment to advancing pharmaceutical research and development.
Conclusion
Moon-Sub Lee's contributions to the field of pharmaceuticals, particularly through his patented method for preparing risperidone, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to impact the industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.